Literature DB >> 33405381

Development and implementation of common data elements for venous thromboembolism research: on behalf of SSC Subcommittee on official Communication from the SSC of the ISTH.

Grégoire Le Gal1, Marc Carrier1, Lana A Castellucci1, Adam Cuker2, John-Bjarne Hansen3, Frederikus A Klok4, Nicole J Langlois1, Jerrold H Levy5, Saskia Middeldorp6, Marc Righini7, Sam Walters8.   

Abstract

Clinical research in venous thromboembolism (VTE) is hindered by variability in the collection and reporting of data and outcomes. A consistent data language facilitates efficiencies, leads to higher quality data, and permits between-study comparisons and evidence synthesis. The International Society on Thrombosis and Haemostasis (ISTH) launched an international task force of more than 50 researchers to develop common data elements for clinical research in venous thromboembolism. The project was organized in seven working groups, each focusing on a topic area: General Core Data Elements; Anticoagulation and Other Therapies; Chronic VTE and Functional Outcomes; Diagnosis of VTE; Malignancy; Perioperative; and Predictors of VTE. The groups met via teleconference to collaboratively identify key data elements and develop definitions and data standards that were structured in a project-specific taxonomy. A Steering Committee met by teleconference and in-person to determine the overall scope of the project and resolve questions arising from the working groups. ISTH held an open public comment period to enable broader stakeholder involvement and feedback. The common data elements were then refined by the working groups to create a set of 512 unique data elements that are publicly available at http://isth.breakthrough.healthcare. The ISTH VTE Common Data Elements are intended to be a living project with ongoing curation, future expansion, and adaptation to meet the needs of the thrombosis and hemostasis research community.
© 2020 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  analysis; clinical research; common data elements; data; standardization; venous thromboembolism

Mesh:

Year:  2021        PMID: 33405381     DOI: 10.1111/jth.15138

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  8 in total

1.  Serial Thromboelastography and the Development of Venous Thromboembolism in Critically Ill Patients With COVID-19.

Authors:  Tanya K Marvi; William B Stubblefield; Benjamin F Tillman; Mark W Tenforde; Manish M Patel; Christopher J Lindsell; Wesley H Self; Carlos G Grijalva; Todd W Rice
Journal:  Crit Care Explor       Date:  2022-01-18

2.  Chronic thromboembolic pulmonary hypertension: anticoagulation and beyond.

Authors:  Karlyn A Martin; Michael J Cuttica
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

3.  Harmonization and standardization of data for a pan-European cohort on SARS- CoV-2 pandemic.

Authors:  Eugenia Rinaldi; Caroline Stellmach; Naveen Moses Raj Rajkumar; Natascia Caroccia; Chiara Dellacasa; Maddalena Giannella; Mariana Guedes; Massimo Mirandola; Gabriella Scipione; Evelina Tacconelli; Sylvia Thun
Journal:  NPJ Digit Med       Date:  2022-06-14

4.  Thromboelastography Parameters and Platelet Count on Admission to the ICU and the Development of Venous Thromboembolism in Patients With Coronavirus Disease 2019.

Authors:  Tanya K Marvi; William B Stubblefield; Benjamin F Tillman; Mark W Tenforde; Leora R Feldstein; Manish M Patel; Wesley H Self; Carlos G Grijalva; Todd W Rice
Journal:  Crit Care Explor       Date:  2021-03-17

5.  Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society.

Authors:  Frederikus A Klok; Walter Ageno; Cihan Ay; Magnus Bäck; Stefano Barco; Laurent Bertoletti; Cecilia Becattini; Jørn Carlsen; Marion Delcroix; Nick van Es; Menno V Huisman; Luis Jara-Palomares; Stavros Konstantinides; Irene Lang; Guy Meyer; Fionnuala Ní Áinle; Stephan Rosenkranz; Piotr Pruszczyk
Journal:  Eur Heart J       Date:  2022-01-25       Impact factor: 29.983

6.  Estimating incidence of venous thromboembolism in COVID-19: Methodological considerations.

Authors:  Linda Nab; Rolf H H Groenwold; Frederikus A Klok; Soerajja Bhoelan; Marieke J H A Kruip; Suzanne C Cannegieter
Journal:  Res Pract Thromb Haemost       Date:  2022-08-15

7.  Clinical and imaging risk factors for the persistence of thromboembolism following acute pulmonary embolism.

Authors:  Weifang Liu; Sheng Xie; Tian Liang; Feiyan Chang; Min Liu; Zhenguo Zhai
Journal:  Quant Imaging Med Surg       Date:  2022-08

8.  Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease.

Authors:  Paul L den Exter; Scott C Woller; Helia Robert-Ebadi; Camila Masias; Pierre-Emmanuel Morange; David Castelli; John-Bjarne Hansen; Geert-Jan Geersing; Deborah M Siegal; Kerstin de Wit; Frederikus A Klok
Journal:  J Thromb Haemost       Date:  2022-06-23       Impact factor: 16.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.